Related Experiment Video
Updated: May 26, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Increased eosinophilic responses in splenectomized patients
Leor Perl1, Oren Pasvolsky1, Lilach Lifshitz2
1Department of Medicine, Meir Medical Center, Kfar-Saba, Israel.
Background:
The spleen is a key organ within the immune system. Its removal is known to bring about adverse effects such as an increased susceptibility to overwhelming infection. Few reports have suggested that the spleen may play a role in controlling eosinophilic responses, mostly based on animal models.
Objectives:
To examine whether the human spleen impacts eosinophil numbers in the blood.
Methods:
We have retrospectively analyzed eosinophil counts and medical records of 29 patients who had undergone splenectomy between 2000 and 2010. Statistical comparison was performed between post-splenectomy blood counts and both pre-splenectomy and control values. Data regarding the clinical settings around hypereosinophilia events were obtained from patient charts.
Results:
An increased rate of eosinophilia was observed after splenectomy as compared with normal individuals. Furthermore, a considerable proportion of patients who had undergone splenectomies (8/29) presented peak eosinophil numbers exceeding 1,000/mm(3), reaching a maximum of 3,070/mm(3). These values were mostly encountered perioperatively or during episodes of acute infection.
Conclusions:
Our data indicate that impaired control of eosinophilic responses is a long-term post-splenectomy effect and is evident in the context of acute stress. We suggest that the spleen plays a significant role in controlling eosinophil levels and that these cells may mediate some of the harmful consequences observed after removal of the spleen.
More Related Videos
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016